Deconstructing Intestinal Immune Tolerance

This project aims to dissect the intestinal immune regulatory network using chemical genetic protein degradation to understand the role of Foxp3+ Treg cells in maintaining immune tolerance.

Subsidie
€ 1.500.000
2024

Projectdetails

Introduction

The intestinal tract is the main site of nutrient absorption and faces constant exposure to complex environmental stimuli. Intestinal barrier integrity and functionality are safeguarded by the intestinal immune system, which must balance its pro- and anti-inflammatory activities to provide protection from pathogenic microorganisms while preventing unwanted reactivity to self-antigens, commensal microbes, and dietary components.

Immune Environment

The intestinal immune environment can be viewed as a multicellular network in which the identity and function of individual cells is intrinsically programmed by transcription factors (TFs) that regulate their gene expression. These cells, in turn, can respond to signals in their environment and impact the behavior of their neighbors, which over time drives changes in tissue physiology.

Limitations of Current Approaches

Conventional genetic knockout approaches offer insufficient temporal resolution to dissect these regulatory layers.

Proposal Overview

In this proposal, we will employ chemical genetic protein degradation using the auxin-inducible degron 2 (AID2) system to “deconstruct” the intestinal immune regulatory network. These studies will focus on the role of Foxp3+ regulatory T (Treg) cells, whose continuous immunosuppressive activity is required to prevent the onset of intestinal inflammation.

Specific Aims

  1. Aim 1: We will use newly generated mouse models to probe the direct gene regulatory functions of key TFs that define intestinal Treg cell subsets.

  2. Aim 2: We will fluorescently label intestinal Treg cells and rapidly degrade the TFs that confer their suppressive activity to study their functionality in situ.

  3. Aim 3: We will use a reversible mosaic protein degradation strategy to study how the signals that precede and promote intestinal Treg cell differentiation shape the developing intestinal immune system.

Conclusion

Together, these studies will provide fundamentally new insights into the regulatory network underlying intestinal immune tolerance.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBHpenvoerder

Land(en)

Austria

Vergelijkbare projecten binnen European Research Council

ERC Starting...

T cell regulation by fed state bacterial metabolites

This project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health.

€ 1.499.548
ERC Starting...

Deciphering Antigen-Specific Circuits Orchestrating Tolerance.

This project aims to uncover the cellular interactions governing peripheral regulatory T cell responses to gut microbes, enhancing understanding of tolerance mechanisms for treating inflammation-related conditions.

€ 2.175.000
ERC Advanced...

Innate lymphoid cells and tissue adaptation to changing metabolic needs

This project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases.

€ 2.379.266
ERC Starting...

Engineered symbionts elucidate gut T cell memory and its (dys)regulation

The GuT Memory project aims to uncover the mechanisms of microbiota-directed Th cell memory to enhance vaccine design and target pathogenic T cells in inflammatory bowel disease.

€ 1.600.683
ERC Advanced...

Microbiota-controlled trafficking of immunosuppressive intestinal T cells into cancer

This project aims to uncover the mechanisms by which intestinal microbiota influences immune checkpoint blockade resistance in cancer through MAdCAM-1 regulation and T cell dynamics.

€ 2.487.834